Compare VALN & EVER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VALN | EVER |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.9M | 604.2M |
| IPO Year | 2021 | 2018 |
| Metric | VALN | EVER |
|---|---|---|
| Price | $5.47 | $15.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $15.50 | ★ $27.00 |
| AVG Volume (30 Days) | 126.9K | ★ 605.3K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 198.86 |
| EPS | N/A | ★ 2.63 |
| Revenue | N/A | ★ $163,349,000.00 |
| Revenue This Year | N/A | $14.73 |
| Revenue Next Year | $93.87 | $11.51 |
| P/E Ratio | ★ N/A | $5.79 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.15 | $13.93 |
| 52 Week High | $12.25 | $28.73 |
| Indicator | VALN | EVER |
|---|---|---|
| Relative Strength Index (RSI) | 29.34 | 48.65 |
| Support Level | N/A | $15.09 |
| Resistance Level | $6.42 | $16.56 |
| Average True Range (ATR) | 0.27 | 0.83 |
| MACD | 0.08 | 0.07 |
| Stochastic Oscillator | 28.74 | 38.44 |
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
EverQuote Inc operates an online marketplace for insurance shopping, connecting consumers with insurance providers, including carriers and agents. Its marketplace is powered by proprietary data and technology platform that delivers high-intent, pre-validated consumer referrals aligned with insurers underwriting and profitability requirements. The platform provides transparency and campaign management tools, enabling providers to evaluate marketing spend performance and manage return on investment. Consumers can visit insurance provider websites, engage by phone, or submit data to receive quotes. Services are free for consumers, and the company derives revenue principally from consumer inquiries sold as referrals to insurance providers. It derives a majority of revenue from Direct channels.